Company Performance Metrics
Radiant Dx develops multi-scale platforms that integrate genomic, transcriptomic, proteomic, epigenetic, and functional data to support cancer diagnostics and biological research. The company uses its Claritas technology to help researchers map tissue-level cellular interactions and distinguish between disease-driving mutations and those shaping
treatment responses. Its structured multi-omics outputs are designed to support AI-driven prediction workflows in oncology and related fields. Radiant Dx also works with organoid models to enable precision cancer diagnostics, drug discovery applications, and mechanistic biological studies. Its offerings target researchers and clinical development teams seeking to connect multi-omics measurements with functional outcomes in cancer and immune-related diseases.
